» Articles » PMID: 37846470

From Mundane to Classic: Sinomenine As a Multi-therapeutic Agent

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2023 Oct 17
PMID 37846470
Authors
Affiliations
Soon will be listed here.
Abstract

Sinomenine is an active substance extracted from the traditional Chinese medicine Sinomenium acutum. Sinomenine has been shown to mediate a wide range of pharmacological actions and is known to possess good anti-inflammatory, immunosuppressive, antitumor, neuroprotective, antiarrhythmic and other pharmacological effects. Understanding the underlying mechanisms and the association between the targets and the pharmaceutical effects on different diseases is crucial to the discovery and design of new treatment strategies. In this review, we aim to give a systematic and comprehensive overview of the research progress of sinomenine over the past 20 years. We first describe the metabolism of sinomenine in vivo and then summarize the pharmacological actions of sinomenine on different diseases. Furthermore, the potential binding properties of sinomenine and the potential of developing new sinomenine-based drugs are also reviewed.

Citing Articles

Sinomenine alleviates neuroinflammation in chronic cerebral hypoperfusion by promoting M2 microglial polarization and inhibiting neuronal pyroptosis via exosomal miRNA-223-3p.

Yang Q, Chen Q, Zhang K, Liu Y, Zheng J, Hu D Acta Neuropathol Commun. 2025; 13(1):48.

PMID: 40045356 PMC: 11881310. DOI: 10.1186/s40478-025-01950-z.


N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis.

Qin Y, Huang Y, Ji X, Gong L, Luo S, Gao J Front Pharmacol. 2024; 15:1389761.

PMID: 39144634 PMC: 11322065. DOI: 10.3389/fphar.2024.1389761.


Sinomenine Alleviates Rheumatoid Arthritis by Suppressing the PI3K-Akt Signaling Pathway, as Demonstrated Through Network Pharmacology, Molecular Docking, and Experimental Validation.

Liu Q, Wang J, Ding C, Chu Y, Jiang F, Hu Y Drug Des Devel Ther. 2024; 18:3523-3545.

PMID: 39135759 PMC: 11317229. DOI: 10.2147/DDDT.S475959.


Sinomenine ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the differentiation of fibroblast into myofibroblast.

Nie Z, Wu J, Xie J, Yin W Heliyon. 2024; 10(13):e33314.

PMID: 39050413 PMC: 11268178. DOI: 10.1016/j.heliyon.2024.e33314.


Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy.

Li S, Lin X, Duan L Front Pharmacol. 2024; 15:1418555.

PMID: 38962319 PMC: 11220463. DOI: 10.3389/fphar.2024.1418555.